I was just reading about this new drug for lupus based on a peptide invented by a French company. It has just started Phase III trials on a fast track - the previous 3 phases (phases I, IIa and IIb) were very encouraging - people were given injections every few weeks and disease reduction was achieved without significant side effects pretty quickly after that. It is being assessed by the FDA in the US for approval to market.
Here's a link for more details if you're interested immupharma.org/lupuzor.
Assuming all goes as expected with the Phase III trial, the drug could be on the market in a year or two, I reckon - but don't take my word for it, I'm not a specialist in these things, it is a simple assumption based on the fact that this drug has started in research and development about 10 years ago, and with the fast track and everything, I do hope something comes up pretty soon.
Of course, anything can go wrong at any stage of this process, or it may be that it would be so expensive that It becomes prohibitive for us in the UK, or who knows what.
But is giving hope, right?